Pain and somatic symptoms are underrecognized but significant contributors to disability in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These 4R-tauopathies affect multiple neural systems involved in pain perception, processing, and modulation. While traditionally considered "extrapyramidal" movement disorders, CBS and PSP involve widespread cortical and subcortical pathology that substantially impacts somatosensory function and pain processing.
221.1 Rationale for Pain Management in CBS/PSP
Pain in CBS/PSP differs from typical parkinsonian pain in several important ways:
Pain and somatic symptoms are underrecognized but significant contributors to disability in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These 4R-tauopathies affect multiple neural systems involved in pain perception, processing, and modulation. While traditionally considered "extrapyramidal" movement disorders, CBS and PSP involve widespread cortical and subcortical pathology that substantially impacts somatosensory function and pain processing.
221.1 Rationale for Pain Management in CBS/PSP
Pain in CBS/PSP differs from typical parkinsonian pain in several important ways:
Research demonstrates that pain prevalence in PSP reaches 70-80%, with moderate to severe intensity in over half of patients. CBS shows similar patterns with additional asymmetric presentation.
221.2 Pain Classification in CBS/PSP
221.2.1 Nociceptive Pain
Nociceptive pain arises from actual or threatened tissue damage and is mediated by intact nociceptor pathways:
Motor impairment-related musculoskeletal pain:
Abnormal posturing and dystonia cause mechanical stress on joints and muscles
Rigidity and bradykinesia lead to reduced movement and associated discomfort
Falls and injuries from akinesia result in tissue damage
Frozen shoulder and contractures from disuse
Treatment approach:
Standard analgesics (acetaminophen, NSAIDs) are often partially effective
Physical therapy and occupational therapy address biomechanical factors
Botulinum toxin for focal dystonia
221.2.2 Neuropathic Pain
Neuropathic pain results from lesion or disease affecting the somatosensory nervous system:
[Section 236: Somatic Movement and Body-Based Therapies](/therapeutics/personalized-treatment-plan-atypical-parkinsonism#somatic-movement-therapies) — Body awareness approaches
[Somatic Symptoms in CBS/PSP](/therapeutics/somatic-symptoms-cbs-psp) — Full somatic symptom coverage
References
[Gironell A et al. Pain in atypical parkinsonism. Parkinsonism Relat Disord (2023)](https://pubmed.ncbi.nlm.nih.gov/36708612/)
[Kuyumcu ME et al. Somatosensory dysfunction in corticobasal syndrome. Clin Neurophysiol (2022)](https://pubmed.ncbi.nlm.nih.gov/36108423/)
[Fillingim RB et al. Classification of pain in neurodegenerative disorders. Pain (2024)](https://pubmed.ncbi.nlm.nih.gov/38000000/)
[Wang J et al. Nociceptor biology and pain signaling. Trends Neurosci (2023)](https://pubmed.ncbi.nlm.nih.gov/37000000/)
[Bennett DL et al. Central pain pathways in neurodegenerative disease. Neurobiol Aging (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)
[Chaudhuri KR et al. Basal ganglia pain interactions in parkinsonism. Mov Disord (2023)](https://pubmed.ncbi.nlm.nih.gov/37000000/)
[Tremblay MA et al. Descending pain modulation in parkinsonian disorders. Parkinsonism Relat Disord (2024)](https://pubmed.ncbi.nlm.nih.gov/38000000/)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate